Literature DB >> 16114888

Evidence for functional importance of usherin/fibronectin interactions in retinal basement membranes.

Gautam Bhattacharya1, Dominic Cosgrove.   

Abstract

Usher syndrome is a genetically heterogeneous disorder characterized by hearing loss with retinitis pigmentosa. Usher syndrome type IIa is the most common of the Usher syndromes, accounting for over half of all cases. The gene encodes a 180 kDa basement membrane glycoprotein called usherin. Here, we demonstrated a specific interaction between usherin and fibronectin in retinal basement membranes. This interaction was confirmed using biochemical, biophysical, and genetic approaches. Surface plasmon resonance assay confirmed that fibronectin binding to usherin is of high affinity and 1:1 stoichiometry. Using a fusion peptide-based co-immunoprecipitation approach, we show that binding to fibronectin occurs at the LE domain of usherin. Recombinant LE domain-specific peptides were engineered that contained single amino acid substitutions corresponding to missense mutations found in humans with Usher syndrome type IIa. Only mutations in loop d of the LE domain abolished the ability of the LE domain to co-immunoprecipitate fibronectin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16114888     DOI: 10.1021/bi050245u

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Identification of 14 novel mutations in the long isoform of USH2A in Spanish patients with Usher syndrome type II.

Authors:  E Aller; T Jaijo; M Beneyto; C Nájera; S Oltra; C Ayuso; M Baiget; M Carballo; G Antiñolo; D Valverde; F Moreno; C Vilela; D Collado; H Pérez-Garrigues; A Navea; J M Millán
Journal:  J Med Genet       Date:  2006-11       Impact factor: 6.318

Review 2.  Basement membranes: cell scaffoldings and signaling platforms.

Authors:  Peter D Yurchenco
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-02-01       Impact factor: 10.005

3.  Tissue-specific genotype-phenotype correlations among USH2A-related disorders in the RUSH2A study.

Authors:  Robert B Hufnagel; Wendi Liang; Jacque L Duncan; Carmen C Brewer; Isabelle Audo; Allison R Ayala; Kari Branham; Janet K Cheetham; Stephen P Daiger; Todd A Durham; Bin Guan; Elise Heon; Carel B Hoyng; Alessandro Iannaccone; Christine N Kay; Michel Michaelides; Mark E Pennesi; Mandeep S Singh; Ehsan Ullah
Journal:  Hum Mutat       Date:  2022-03-21       Impact factor: 4.700

4.  Biochemical characterization of native Usher protein complexes from a vesicular subfraction of tracheal epithelial cells.

Authors:  Marisa Zallocchi; Joseph H Sisson; Dominic Cosgrove
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

5.  Localization and expression of clarin-1, the Clrn1 gene product, in auditory hair cells and photoreceptors.

Authors:  Marisa Zallocchi; Daniel T Meehan; Duane Delimont; Charles Askew; Suneetha Garige; Michael Anne Gratton; Christie A Rothermund-Franklin; Dominic Cosgrove
Journal:  Hear Res       Date:  2009-06-16       Impact factor: 3.208

6.  Knockout of ush2a gene in zebrafish causes hearing impairment and late onset rod-cone dystrophy.

Authors:  Shanshan Han; Xiliang Liu; Shanglun Xie; Meng Gao; Fei Liu; Shanshan Yu; Peng Sun; Changquan Wang; Stephen Archacki; Zhaojing Lu; Xuebin Hu; Yayun Qin; Zhen Qu; Yuwen Huang; Yuexia Lv; Jiayi Tu; Jingzhen Li; Tinsae Assefa Yimer; Tao Jiang; Zhaohui Tang; Daji Luo; Fangyi Chen; Mugen Liu
Journal:  Hum Genet       Date:  2018-09-21       Impact factor: 4.132

7.  Current understanding of usher syndrome type II.

Authors:  Jun Yang; Le Wang; Hongman Song; Maxim Sokolov
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

8.  Retinal organoids and microfluidic chip-based approaches to explore the retinitis pigmentosa with USH2A mutations.

Authors:  Ting Su; Liying Liang; Lan Zhang; Jianing Wang; Luyin Chen; Caiying Su; Jixing Cao; Quan Yu; Shuai Deng; Hon Fai Chan; Shibo Tang; Yonglong Guo; Jiansu Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-09-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.